Advertisement
“Precision Medicine: New Directions in Atherosclerotic Cardiovascular Disease Prevention”Christie M. Ballantyne, M.D.
Professor of Medicine and Chief
Sections of Cardiology and Cardiovascular Research
Baylor College of Medcine
More about Dr. Ballantyne from the Baylor website:
https://www.bcm.edu/people-search/christie-ballantyne-17846
Location:
1-101 Microbiology Research Facility (MRF)
689 23rd Ave SE, Minneapolis, MN
Map: https://campusmaps.umn.edu/microbiology-research-facility
Webcast @ z.umn.edu/lhi-webcast
Learning Objectives
1. Describe current approach and role of risk assessment to guide intensity of lifestyle interventions and pharmacotherapy in cardiovascular prevention
2. Summarize genetic testing available and current role in cardiovascular disease prevention
3. Discuss the conceptual framework for addressing residual cardiovascular disease risk with a focus on triglycerides and inflammation
4. Describe the association of clonal hematopoiesis of indeterminate potential (CHIP) to development of cardiovascular disease and the potential role of a high risk CHIP score algorithm
Advertisement
Event Venue & Nearby Stays
689 SE 23rd Ave, Minneapolis, MN 55455-1507, United States